NeoGenomics, Inc. (NASDAQ:NEO) Q4 2025 Earnings Call Transcript February 17, 2026 NeoGenomics, Inc. misses on earnings ...
Good morning, ladies and gentlemen, and welcome to the Neo Performance Materials Inc. Third Quarter 2024 Earnings Conference Call. At this time all lines are in a listen-only mode. Following the ...
NeoGenomics Inc (NASDAQ:NEO) reported its fourth-quarter 2025 earnings, surpassing analyst expectations with an earnings per share (EPS) of $0.06, compared to the forecasted $0.04, resulting in a 50% ...
Earnings call NeoGenomics reported Q4 2025 revenue of $190M, up 11% YoY, driven by 16% clinical revenue growth and 23% NGS growth. Full-year 2025 revenue rose 10% to $727M. For 2026, the company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results